Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II

Ng, Jeremy Y.; Liu, Henry; Wang, Michelle Chenghuazou

doi:10.1186/s12906-023-04062-0

BMC Complementary Medicine and Therapies

Table 4 Scaled Domain Percentages for Appraisers of Each Guideline

From: Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II

Guideline		Domain score (%)
Guideline		Scope and purpose	Stakeholder involvement	Rigour of development	Clarity of presentation	Applicability	Editorial Independence
Raine et al. 2022 [37] & Spinelli et al. 2022 [38]	Overall Guideline	100.0	69.4	86.5	100.0	25.0	58.3
Raine et al. 2022 [37] & Spinelli et al. 2022 [38]	CAM Section	100.0	27.8	64.6	55.6	2.1	58.3
Lodyga et al. 2021 [42]	Overall Guideline	100.0	30.6	46.9	100.0	14.6	0.0
Lodyga et al. 2021 [42]	CAM Section	100.0	13.9	32.3	69.4	0.0	0.0
Miehlke et al. 2021 [43]	Overall Guideline	88.9	72.2	68.8	91.7	4.2	70.8
Miehlke et al. 2021 [43]	CAM Section	88.9	33.3	63.5	52.8	2.1	70.8
Levine et al. 2020 [47]	Overall Guideline	91.7	47.2	43.8	77.8	0.0	50.0
Levine et al. 2020 [47]	CAM Section	91.7	33.3	29.2	58.3	0.0	50.0
Colombel et al. 2019 [48]	Overall Guideline	86.1	44.4	26.0	94.4	6.25	50.0
Colombel et al. 2019 [48]	CAM Section	86.1	27.8	21.9	91.7	0.0	50
Ko et al. 2019 [53]	Overall Guideline	94.4	50.0	65.6	94.4	8.3	83.3
Ko et al. 2019 [53]	CAM Section	94.4	25.0	59.4	69.4	0.0	83.3
Kucharzik et al. 2019 [54]	Overall Guideline	100.0	86.1	67.7	100.0	35.4	87.5
Kucharzik et al. 2019 [54]	CAM Section	100.0	94.4	54.2	94.4	6.3	87.5
Panaccione et al. 2019a [56] & Panaccione et al. 2019b [57]	Overall Guideline	100.0	91.7	67.7	100.0	10.4	91.7
Panaccione et al. 2019a [56] & Panaccione et al. 2019b [57]	CAM Section	100.0	33.3	62.5	77.8	0.0	91.7
Sood et al. 2019 [59]	Overall Guideline	91.7	38.9	58.3	83.3	14.6	75.0
Sood et al. 2019 [59]	CAM Section	91.7	13.9	52.1	75.0	0.0	75.0
Forbes et al. 2017 [66]	Overall Guideline	86.1	30.6	60.4	94.4	27.1	100.0
Forbes et al. 2017 [66]	CAM Section	86.1	13.9	60.4	88.9	12.5	100.0
Nguyen et al. 2017 [68]	Overall Guideline	91.7	63.9	68.8	94.4	18.8	66.7
Nguyen et al. 2017 [68]	CAM Section	91.7	22.2	60.4	55.6	0.0	66.7
Bernstein et al. 2016 [69]	Overall Guideline	97.2	52.8	28.1	75.0	25.0	25.0
Bernstein et al. 2016 [69]	CAM Section	97.2	30.6	17.7	33.3	0.0	25.0
Harbord et al. 2016 [70]	Overall Guideline	80.6	33.3	29.2	91.7	12.5	29.2
Harbord et al. 2016 [70]	CAM Section	80.6	8.3	20.8	61.1	8.3	29.2
Bressleret al. 2015 [71]	Overall Guideline	97.2	58.3	66.7	100.0	4.2	91.7
Bressleret al. 2015 [71]	CAM Section	97.2	22.2	60.4	72.2	0.0	91.7
Eliadou et al. 2015 [72]	Overall Guideline	100.0	44.4	28.1	69.4	10.4	25.0
Eliadou et al. 2015 [72]	CAM Section	100.0	16.7	22.9	27.8	0.0	25.0
Fichera & Zoccali 2015 [73]	Overall Guideline	72.2	30.6	34.4	86.1	0.0	0.0
Fichera & Zoccali 2015 [73]	CAM Section	72.2	11.1	25.0	36.1	0.0	0.0
Lee et al. 2014 [77]	Overall Guideline	100.0	80.6	76.0	83.3	18.8	45.8
Lee et al. 2014 [77]	CAM Section	100.0	33.3	72.9	47.2	4.2	45.8
Ueno et al. 2013 [83]	Overall Guideline	83.3	80.6	56.3	88.9	4.2	83.3
Ueno et al. 2013 [83]	CAM Section	83.3	33.3	43.8	55.6	2.1	83.3
Mowat et al. 2011 [85]	Overall Guideline	77.8	72.2	59.4	91.7	37.5	50.0
Mowat et al. 2011 [85]	CAM Section	77.8	33.3	47.9	94.4	2.1	50.0

Back to article page

ISSN: 2662-7671

Contact us

Submission enquiries: bmccomplementarymedicineandtherapies@biomedcentral.com
General enquiries: ORSupport@springernature.com